Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Analysts at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of Kymera Therapeutics in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($0.79) per share for the quarter. Leerink Partnrs currently has […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Jeffrey W. Albers sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $30.05, for a total value of $300,500.00. The transaction was disclosed in a legal filing with the SEC, […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Jeffrey W. Albers sold 10,000 shares of the stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $30.05, for a total transaction of $300,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible […]
Kymera Therapeutics (NASDAQ:KYMR) Stock Price Up 5 7% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AtonRa Partners Sells 2,775 Shares of Kymera Therapeutics, Inc (NASDAQ:KYMR) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.